Elevated procalcitonin as a diagnostic marker in meningococcal disease

  • G. D. Mills
  • H. M. Lala
  • M. R. Oehley
  • A. B. Craig
  • K. Barratt
  • D. Hood
  • C. N. Thornley
  • A. Nesdale
  • N. E. Manikkam
  • P. Reeve


Patients with meningococcal disease who seek medical attention can create a diagnostic dilemma for clinicians due to the nonspecific nature of the disease’s presentation. This study assesses the diagnostic accuracy of procalcitonin levels in the setting of meningococcal disease. Two emergency department cohorts (A and B) were studied between 2002 and 2005, during the current epidemic of serogroup B meningococcal disease in New Zealand. Cohort A consisted of 171 patients, all with confirmed meningococcal disease (84 children, 87 adults). Cohort B consisted of a large (n=1,524) consecutively recruited population of febrile patients who presented to the emergency department, 28 of whom had confirmed meningococcal disease. Within the meningococcal disease cohort (cohort A), the geometric mean procalcitonin level was 9.9 ng/ml, with levels being higher in children than in adults (21.6 vs. 4.6 ng/ml, p=0.01). The overall sensitivity of elevated procalcitonin, using a cutoff of 2.0 ng/ml in children and 0.5 ng/ml in adults, was 0.93 (95%CI: 0.88–0.96). Despite the higher cutoff level for paediatric patients, a trend towards greater sensitivity existed in children (0.96 vs. 0.90; p=0.08). Elevated procalcitonin was correlated with whole blood meningococcal load (r=0.50) and Glasgow Meningococcal Sepsis Prognostic Score (r=0.40). Within the cohort of patients who were febrile on presentation (cohort B), the specificity of elevated procalcitonin in meningococcal disease was 0.85 (95% CI: 0.83–0.87), the positive and negative likelihood ratios were 6.1 and 0.08, respectively, and the sensitivity of elevated procalcitonin (0.93; 95% CI: 0.76–0.99) was corroborated. Measurement of procalcitonin is a useful tool in patients with nonspecific febrile illnesses when the possibility of meningococcal disease is present. The diagnostic accuracy surpasses that of current early laboratory markers, allowing results to be used to guide decisions about patient management.


  1. 1.
    Herrick W (1919) Extrameningeal meningococcus infections. Arch Intern Med 23:409–418Google Scholar
  2. 2.
    Wells LC, Smith JC, Weston VC, Collier J, Rutter N (2001) The child with a non-blanching rash: how likely is meningococcal disease? Arch Dis Child 85:218–222PubMedCrossRefGoogle Scholar
  3. 3.
    Wilks D, Lever AM (1996) Reasons for delay in administration of antibiotics to patients with meningitis and meningococcaemia. J Infect 32:49–51PubMedCrossRefGoogle Scholar
  4. 4.
    Riordan FA, Thomson AP, Sills JA, Hart CA (1996) Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ 313:1255–1256PubMedGoogle Scholar
  5. 5.
    Nadel S, Britlo J, Boey R, Maconochie I, Habibi P, Levin M (1998) Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med 15:298–303PubMedGoogle Scholar
  6. 6.
    Dashefsky B, Teele D, Klein J (1983) Unsuspected meningococcemia. J Pediatr 102:69–72PubMedCrossRefGoogle Scholar
  7. 7.
    Martin D, McDowell R, Sneyd E, Baker M (2004) The epidemiology of meningococcal disease in New Zealand in 2003. New Zealand Ministry of Health, Institute of Environmental Science and Research, Wellington, pp 1–32Google Scholar
  8. 8.
    Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guerin S, Ravilly S, Lefevre H, Royer C, Lacombe C, Palmer P, Bohuon C (1999) Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 18:875–881PubMedCrossRefGoogle Scholar
  9. 9.
    Van Rossum AMC, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4:620–630PubMedCrossRefGoogle Scholar
  10. 10.
    Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217PubMedCrossRefGoogle Scholar
  11. 11.
    Carrol ED, Thomson AP, Hart CA (2002) Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20:1–9PubMedCrossRefGoogle Scholar
  12. 12.
    Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605–1608PubMedCrossRefGoogle Scholar
  13. 13.
    Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, Reinhart K (1999) Sensitivity and specificity of various markers of inflammation for the prediction of tumour necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 27:1814–1818PubMedCrossRefGoogle Scholar
  14. 14.
    Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, Bertran JC (1999) High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 28:1313–1316PubMedCrossRefGoogle Scholar
  15. 15.
    Bugden SA, Coles C, Mills GD (2004) The potential role of procalcitonin in the emergency department management of febrile young adults during a sustained meningococcal epidemic. Emerg Med Austral 16:114–119CrossRefGoogle Scholar
  16. 16.
    Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB (2001) Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39:1553–1558PubMedCrossRefGoogle Scholar
  17. 17.
    Meisner M (2000) Procalcitonin. A new, innovative infection parameter. Biochemical and clinical aspects. Thieme, Stuttgart, p 180Google Scholar
  18. 18.
    Derkx HH, van den Hoek J, Redekop WK, Bijlmer RP, van Deventer SJ, Bossuyt PM (1996) Meningococcal disease: a comparison of eight severity scores in 125 children. Intensive Care Med 22:1433–1441PubMedCrossRefGoogle Scholar
  19. 19.
    Lopez AF, Cubells CL, Garcia JJG, Pou JF (2003) Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicentre study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 22:895–903CrossRefGoogle Scholar
  20. 20.
    Carrol ED, Newland P, Riordan FA, Thomson AP, Curtis N, Hart CA (2002) Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 86:282–285PubMedCrossRefGoogle Scholar
  21. 21.
    Van der Kaay DC, de Kleijn ED, de Rijke YB, Hop WC, de Groot R, Hazelzet JA (2002) Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606–1612PubMedCrossRefGoogle Scholar
  22. 22.
    Casado-Flores J, Blanco-Quiros A, Asensio J, Arranz E, Garrote JA, Nieto M (2003) Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 4:190–195PubMedCrossRefGoogle Scholar
  23. 23.
    Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA (1999) Diagnostic markers of infection: comparison of procalcitonin with C-reactive protein and leukocyte count. Arch Dis Child 81:417–421PubMedCrossRefGoogle Scholar
  24. 24.
    Leclerc F, Leteurtre S, Noizet O, Dorkenoo A, Sadik A, Cremer R, Fourier C (2002) Procalcitonin as a prognostic marker in children with meningococcal septic shock. Arch Dis Child 87:450PubMedCrossRefGoogle Scholar
  25. 25.
    Karabocuoglu M, Kaya O (2000) Plasma procalcitonin levels correlated with the severity of systemic meningococcal disease in children. Crit Care Med 28(Suppl):A170Google Scholar
  26. 26.
    Marzouk O, Bestwick K, Thomson APJ, Sills JA, Hart CA (1993) Variation in serum C-reactive protein across the clinical spectrum of meningococcal disease. Acta Paediatr 82:729–733PubMedCrossRefGoogle Scholar
  27. 27.
    Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R (1997) Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 25:640–646PubMedCrossRefGoogle Scholar
  28. 28.
    Brunkhorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24:888–892PubMedCrossRefGoogle Scholar
  29. 29.
    Nylen E, Muller B, Becker KL, Snider R (2004) The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 36:823–824CrossRefGoogle Scholar
  30. 30.
    Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600–607PubMedCrossRefGoogle Scholar
  31. 31.
    Carrol ED, Newland P, Thomson APJ, Hart CA (2005) Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med 33:224–225PubMedCrossRefGoogle Scholar
  32. 32.
    Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson APJ, Kaczmarski EB, Hart CA (2002) Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 86:44–46PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • G. D. Mills
    • 1
  • H. M. Lala
    • 1
  • M. R. Oehley
    • 1
  • A. B. Craig
    • 2
  • K. Barratt
    • 3
  • D. Hood
    • 4
  • C. N. Thornley
    • 6
  • A. Nesdale
    • 7
  • N. E. Manikkam
    • 2
  • P. Reeve
    • 5
  1. 1.Infectious Diseases DepartmentWaikato HospitalHamiltonNew Zealand
  2. 2.Paediatric DepartmentWaikato District Health BoardHamiltonNew Zealand
  3. 3.Molecular Biology DepartmentWaikato District Health BoardHamiltonNew Zealand
  4. 4.Waikato Public Health ServiceWaikato District Health BoardHamiltonNew Zealand
  5. 5.General MedicineWaikato District Health BoardHamiltonNew Zealand
  6. 6.Auckland Regional Public Health ServiceAuckland District Health BoardAucklandNew Zealand
  7. 7.Wellington Regional Public HealthHutt Valley District Health BoardLower HuttNew Zealand

Personalised recommendations